Sun Jian David Acquires Shares in 111, Inc.

Insider Sun Jian David bought 378,737 shares of 111, Inc. on May 11, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 2:01 PM EDT

Key Points

Sun Jian David purchased 378,737 shares of 111, Inc. on May 11, 2026.
111, Inc. trades on NasdaqGM under the ticker YI, with a market cap of $40.2 million.
Recent insider sales include Sun Jian David selling shares in June 2026.

Sun Jian David recently made a significant purchase of 378,737 shares in 111, Inc. (NasdaqGM: YI) on May 11, 2026. This transaction was not part of a pre-planned trading program and highlights his active involvement with the company.

Insider Buying and Selling at 111, Inc.

On May 11, 2026, Sun Jian David bought 378,737 shares of 111, Inc. This was not a planned transaction, indicating a personal decision to increase his stake in the company. In contrast, Sun Jian David also sold various amounts of shares in June 2026, including 111,100 shares on June 11 and 115,440 shares on June 10.

Other Institutional Activity in 111, Inc.

Several other institutional investors have also been active in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, ending with 13,014 shares valued at approximately $84,851. On the other hand, Serenus Wealth Advisors, LLC reduced its position by 64 shares to hold 4,320 shares worth about $321,334. Citigroup Inc acquired 207 shares, bringing its total to 207 shares valued at $1,341. Morgan Stanley trimmed its stake by 27 shares, leaving it with 113 shares valued at $737.

111, Inc. Stock Snapshot

Shares of 111, Inc. (NasdaqGM: YI) recently traded around $4.57. The company has a market capitalization of approximately $40.2 million and a forward P/E ratio of 32.64. The stock's 52-week range has been between $2.48 and $11.17. Its 50-day moving average is $5.88, and the 200-day moving average is $5.40. The company's current ratio is 1.08, with a quick ratio of 0.37 and a debt-to-equity ratio of 150.93.

Recent Earnings

For its most recent earnings, 111, Inc. reported revenue of about $11.39 billion, though it faced a revenue decline of 33.1%. The company has a negative net margin of 0.75% and a return on equity of -14.84%. The next earnings announcement is scheduled for March 19, 2026.

About 111, Inc.

111, Inc. operates an integrated online and offline platform in the healthcare market in China. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers through its B2C and B2B segments. The company provides supply chain integration, product promotion, customer analytics, and various pharmacy-related services. Headquartered in Shanghai, 111, Inc. was founded in 2010 and is led by CEO Mr. Junling Liu.

Bottom Line

Sun Jian David's recent purchase of 111, Inc. shares reflects his confidence in the company's potential. Investors often track insider activity as it can provide insights into a company's prospects. However, it's essential to remember that 13F filings and insider reports are backward-looking and may not represent current positions or strategies.